3BDO, a butyrolactone derivative, could target FKBP1A and activate the mTOR signaling pathway. It inhibits autophagy in HUVECs.
For research use only. We do not sell to patients.
| Name | 3BDO |
|---|---|
| Iupac Chemical Name | Pentonic acid, 2,3-dideoxy-5-O-(2-nitrophenyl)-2-(phenylmethyl)- |
| Synonyms | 3BDO |
| Molecular Formula | C18H19NO6 |
| Molecular Weight | 345.351 |
| Smile | OC(COC1=CC=CC=C1[N+]([O-])=O)CC(CC2=CC=CC=C2)C(O)=O |
| InChiKey | HLYXFAINZWNIRV-UHFFFAOYSA-N |
| InChi | InChI=1S/C18H19NO6/c20-15(12-25-17-9-5-4-8-16(17)19(23)24)11-14(18(21)22)10-13-6-2-1-3-7-13/h1-9,14-15,20H,10-12H2,(H,21,22) |
| CAS Number | 890405-51-3 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Off-white solid to white solid |
|---|---|
| Purity | >98% |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |